SOPHiA GENETICS SA
SOPH
$4.59
-$0.04-0.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 81.18M | 77.27M | 73.30M | 69.69M | 67.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 81.18M | 77.27M | 73.30M | 69.69M | 67.17M |
| Cost of Revenue | 26.56M | 25.19M | 23.81M | 22.45M | 21.43M |
| Gross Profit | 54.62M | 52.08M | 49.49M | 47.23M | 45.74M |
| SG&A Expenses | 92.12M | 88.68M | 84.55M | 80.17M | 75.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 122.00K | 114.00K | -47.00K | -233.00K | -185.00K |
| Total Operating Expenses | 153.36M | 148.21M | 143.13M | 137.02M | 131.02M |
| Operating Income | -72.18M | -70.93M | -69.83M | -67.34M | -63.85M |
| Income Before Tax | -79.67M | -77.49M | -72.46M | -71.38M | -64.76M |
| Income Tax Expenses | 1.26M | 1.51M | 2.52M | 2.01M | 1.41M |
| Earnings from Continuing Operations | -80.94 | -79.00 | -74.98 | -73.40 | -66.17 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -80.94M | -79.00M | -74.98M | -73.40M | -66.17M |
| EBIT | -72.18M | -70.93M | -69.83M | -67.34M | -63.85M |
| EBITDA | -68.48M | -67.33M | -66.18M | -63.50M | -59.78M |
| EPS Basic | -1.18 | -1.17 | -1.12 | -1.10 | -1.00 |
| Normalized Basic EPS | -0.73 | -0.72 | -0.68 | -0.67 | -0.61 |
| EPS Diluted | -1.18 | -1.17 | -1.12 | -1.10 | -1.00 |
| Normalized Diluted EPS | -0.73 | -0.72 | -0.68 | -0.67 | -0.61 |
| Average Basic Shares Outstanding | 274.74M | 269.99M | 267.40M | 265.99M | 264.59M |
| Average Diluted Shares Outstanding | 274.74M | 269.99M | 267.40M | 265.99M | 264.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |